Researchers from St. Jude Children’s Research Hospital have identified the first genetic variation that is associated with increased risk and severity of peripheral neuropathy following treatment with a widely used anti-cancer drug. Investigators also found evidence of how it may be possible to protect young leukemia patients without jeopardizing cures. The opensource study is published in the Journal of the American Medical Association. The study … Continue reading Researchers identify gene mutation that raises risk of nerve damage in leukemia patients using Vincristine.